L&K Biomed Ltd. (KOSDAQ:156100)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,440.00
-400.00 (-5.10%)
At close: Apr 28, 2026
10.39%
Market Cap 166.29B
Revenue (ttm) 38.92B
Net Income (ttm) -16.30B
Shares Out 22.35M
EPS (ttm) -802.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 164,383
Average Volume 129,602
Open 7,970.00
Previous Close 7,840.00
Day's Range 7,440.00 - 8,100.00
52-Week Range 5,570.00 - 16,400.00
Beta 0.92
RSI 39.00
Earnings Date May 14, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2008
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 156100
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.